ZA200803086B - Bisphosphonate formulation - Google Patents

Bisphosphonate formulation

Info

Publication number
ZA200803086B
ZA200803086B ZA2008/03086A ZA200803086A ZA200803086B ZA 200803086 B ZA200803086 B ZA 200803086B ZA 2008/03086 A ZA2008/03086 A ZA 2008/03086A ZA 200803086 A ZA200803086 A ZA 200803086A ZA 200803086 B ZA200803086 B ZA 200803086B
Authority
ZA
South Africa
Prior art keywords
bisphosphonate formulation
bisphosphonate
formulation
Prior art date
Application number
ZA2008/03086A
Other languages
English (en)
Inventor
Anna Marie Elizabeth Power
Paul Harrison
Original Assignee
Selamine Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0518952A external-priority patent/GB2430156A/en
Priority claimed from GB0610311A external-priority patent/GB0610311D0/en
Application filed by Selamine Ltd filed Critical Selamine Ltd
Publication of ZA200803086B publication Critical patent/ZA200803086B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA2008/03086A 2005-09-16 2008-04-08 Bisphosphonate formulation ZA200803086B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0518952A GB2430156A (en) 2005-09-16 2005-09-16 Bisphosphonate formulation
GB0610311A GB0610311D0 (en) 2006-05-24 2006-05-24 Bisphosphonate formulation
PCT/GB2006/003457 WO2007031785A2 (en) 2005-09-16 2006-09-15 Bisphosphonate formulation

Publications (1)

Publication Number Publication Date
ZA200803086B true ZA200803086B (en) 2009-12-30

Family

ID=37865306

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2008/03086A ZA200803086B (en) 2005-09-16 2008-04-08 Bisphosphonate formulation

Country Status (8)

Country Link
EP (1) EP1937362B1 (https=)
JP (1) JP2009508834A (https=)
AU (1) AU2006290519B2 (https=)
BR (1) BRPI0615770A2 (https=)
CA (1) CA2622322A1 (https=)
NZ (1) NZ567200A (https=)
WO (1) WO2007031785A2 (https=)
ZA (1) ZA200803086B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1972341A1 (en) * 2007-03-23 2008-09-24 Novartis AG Pharmaceutical compositions comprising a bisphosphonate and vitamin D
EP2055297A1 (en) * 2007-11-05 2009-05-06 Merz Pharma GmbH & Co. KGaA Therapy option for recoloration of hair via bisphosphonates by physiological repigmentation with age-related and/or premature "grayed" patients
TR200900879A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Aktif maddelerin tek bir dozaj formunda kombine edildiği farmasötik bileşimler
TR200900878A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL129127A0 (en) * 1996-10-04 2000-02-17 Merck & Co Inc Liquid alendronate formulations
US5914135A (en) 1997-04-16 1999-06-22 Mcneil-Ppc, Inc. Liquid antacid compositions
US6015801A (en) * 1997-07-22 2000-01-18 Merck & Co., Inc. Method for inhibiting bone resorption
PT1175904E (pt) * 1997-07-22 2007-04-30 Merck & Co Inc Alendronato para utilização no tratamento da osteoporose
US20040062802A1 (en) * 1998-04-02 2004-04-01 Hermelin Victor M. Maximizing effectiveness of substances used to improve health and well being
AU2001251432A1 (en) * 2000-04-07 2001-10-23 The Board Of Regents Of The University Of Texas System Unique compositions of zwitterionic phospholipids and bisphosphonates and use ofthe compositions as bisphosphate delivery systems with reduced gi toxicity
GB0029111D0 (en) * 2000-11-29 2001-01-10 Novartis Ag Organic compounds
JP2005516928A (ja) * 2001-12-13 2005-06-09 メルク　エンド　カムパニー　インコーポレーテッド 骨異常のためのビスホスホネート液体製剤
CA2488581C (en) * 2002-03-28 2011-06-07 The Procter & Gamble Company Hair bleach kit comprising a colorant for improved visual application
US7595345B2 (en) * 2003-11-20 2009-09-29 Eli Lilly And Company Vitamin D receptor modulators
DK2283825T3 (da) 2004-05-24 2022-06-27 Theramex Hq Uk Ltd Enterisk fast oral doseringsform af en bisfosfonat indeholdende et chelateringsmiddel

Also Published As

Publication number Publication date
EP1937362B1 (en) 2013-03-27
WO2007031785A3 (en) 2007-05-31
WO2007031785A2 (en) 2007-03-22
EP1937362A2 (en) 2008-07-02
CA2622322A1 (en) 2007-03-22
JP2009508834A (ja) 2009-03-05
NZ567200A (en) 2010-08-27
BRPI0615770A2 (pt) 2011-05-24
AU2006290519B2 (en) 2012-10-18
AU2006290519A1 (en) 2007-03-22

Similar Documents

Publication Publication Date Title
IL189856A0 (en) New formulation
GB2424581B (en) Formulations
PL1879451T3 (pl) Innowacyjna formulacja
GB0608098D0 (en) Formulation
EP2046930A4 (en) FORMULATIONS BASED ON RHAMNOLIPIDS
GB0518783D0 (en) Indolizine compounds
IL191791A0 (en) Hcv prodrug formulation
ZA200802602B (en) Controlled release formulation
IL185773A0 (en) Formulations
EP1909584A4 (en) PRENYLFLAVONOID FORMULATIONS
GB0605780D0 (en) Formulations
TWI370115B (en) New formulation
GB0526419D0 (en) Formulation
GB0618697D0 (en) Formulations
GB0517673D0 (en) Formulation
GB0610336D0 (en) Formulations
ZA200803086B (en) Bisphosphonate formulation
GB0625312D0 (en) Formulation
GB0625095D0 (en) Formulation
PL1855661T3 (pl) Preparaty zawierające awiptadil
GB0501956D0 (en) Nebulizer formulation
GB0718404D0 (en) Formulations
GB0501030D0 (en) Formulation
GB0612809D0 (en) Formulation
LT1928232T (lt) Kieta kompozicija